SCHEMBL4952302

SCHEMBL4952302

O=C(O)c1sc(C2=CCCCC2)cc1NC1CCN2C(=O)CCC2C1

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.31
HDAC2 Q92769 2/20 0.31
ACMSD Q8TDX5 1/20 0.31
AKR1C3 P42330 1/20 0.30
AKR1C2 P52895 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2106348 0.90 KDM4E (0.33) HDAC1HDAC2
SCHEMBL2611950 0.73 NR1I2 (0.39)
SCHEMBL2105107 0.73 NR1I2 (0.39)
SCHEMBL14641442 0.72
SCHEMBL14818400 0.71 ACMSD (0.39) HDAC1HDAC2ACMSD
SCHEMBL2107701 0.69 NR1I2 (0.32)
SCHEMBL14549438 0.67 KDM4E (0.39) HDAC1HDAC2
SCHEMBL2620438 0.67 KDM4E (0.46) HDAC1HDAC2
SCHEMBL14818387 0.67 KDM4E (0.39) HDAC1HDAC2
SCHEMBL2611971 0.64 KDM4E (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2546246-A2 Compounds and methods for the treatment or prevention of flavivirus infections Virochem Pharma Inc. (CA) 2013-01-16 EP disclosed
EP-2543664-A1 Compounds and methods for the treatment or prevention of flavivirus infections Virochem Pharma Inc. (CA) 2013-01-09 EP disclosed
EP-1879879-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS Virochem Pharma Inc. (CA) 2008-01-23 EP disclosed
WO-2006119646-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC. (CA) 2006-11-16 WO disclosed